These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9923578)

  • 1. Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors.
    Gass RJ; Gal J; Fogle PW; Detmar-Hanna D; Gerber JG
    Eur J Clin Pharmacol; 1998; 54(9-10):741-7. PubMed ID: 9923578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.
    Eagling VA; Back DJ; Barry MG
    Br J Clin Pharmacol; 1997 Aug; 44(2):190-4. PubMed ID: 9278209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
    Eagling VA; Wiltshire H; Whitcombe IW; Back DJ
    Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions.
    Decker CJ; Laitinen LM; Bridson GW; Raybuck SA; Tung RD; Chaturvedi PR
    J Pharm Sci; 1998 Jul; 87(7):803-7. PubMed ID: 9649346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.
    Koudriakova T; Iatsimirskaia E; Utkin I; Gangl E; Vouros P; Storozhuk E; Orza D; Marinina J; Gerber N
    Drug Metab Dispos; 1998 Jun; 26(6):552-61. PubMed ID: 9616191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
    Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
    Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.
    Lillibridge JH; Liang BH; Kerr BM; Webber S; Quart B; Shetty BV; Lee CA
    Drug Metab Dispos; 1998 Jul; 26(7):609-16. PubMed ID: 9660842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir.
    Pfister M; Labbé L; Lu JF; Hammer SM; Mellors J; Bennett KK; Rosenkranz S; Sheiner LB;
    Clin Pharmacol Ther; 2002 Aug; 72(2):133-41. PubMed ID: 12189360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.
    Gill HJ; Tingle MD; Park BK
    Br J Clin Pharmacol; 1995 Dec; 40(6):531-8. PubMed ID: 8703658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inactivation of CYP3A by HIV protease inhibitors.
    Ernest CS; Hall SD; Jones DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):583-91. PubMed ID: 15523003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
    Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
    Niwa T; Tani M; Suzuki A; Murakami M
    Drug Metab Bioanal Lett; 2023; 16(2):73-80. PubMed ID: 37649294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
    Kinirons MT; O'Shea D; Downing TE; Fitzwilliam AT; Joellenbeck L; Groopman JD; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1993 Dec; 54(6):621-9. PubMed ID: 8275617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
    Fitzsimmons ME; Collins JM
    Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
    van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers.
    Makhova AA; Shikh EV; Bulko TV; Sizova ZM; Shumyantseva VV
    Drug Metab Pers Ther; 2019 Oct; 34(3):. PubMed ID: 31603853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.
    Kenworthy KE; Bloomer JC; Clarke SE; Houston JB
    Br J Clin Pharmacol; 1999 Nov; 48(5):716-27. PubMed ID: 10594474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir.
    von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Duan SX; Fogelman SM; Daily JP; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Feb; 38(2):106-11. PubMed ID: 9549640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.